In vivo nanoneurotoxicity screening using oxidative stress and neuroinflammation paradigms

详细信息    查看全文

• 作者：Youngsoon Kim ; Seong Deok Kong ; Li-Han Chen ; Thomas R. Pisanic II ; Sungho Jin ; Veronica I. Shubayev
• 关键词：Magnetic nanoparticles ; Nanotoxicity ; Blood&ndash ; brain barrier ; Iron oxide ; Theranostic
• 刊名：Nanomedicine: Nanotechnology, Biology and Medicine
• 出版年：2013
• 出版时间：October, 2013
• 年：2013
• 卷：9
• 期：7
• 页码：1057-1066
• 全文大小：3840 K

文摘

Iron oxide nanoparticles (IONPs) are promising neuroimaging agents and molecular cargo across neurovascular barriers. Development of intrinsically safe IONP chemistries requires a robust in vivo nanoneurotoxicity screening model. Herein, we engineered four IONPs of different surface and core chemistries: DMSA-Fe₂O₃, DMSA-Fe₃O₄, PEG-Fe₃O₄ and PEG-Au-Fe₃O₄. Capitalizing on the ability of the peripheral nervous system to recruit potent immune cells from circulation, we characterized a spatiotemporally controlled platform for the study of in vivo nanobiointerfaces with hematogenous immune cells, neuroglial and neurovascular units after intraneural IONP delivery into rat sciatic nerve. SQUID magnetometry and histological iron stain were used for IONP tracking. Among the IONPs, DMSA-Fe₂O₃ NPs were potent pro-apoptotic agents in nerve, with differential ability to regulate oxidative stress, inflammation and apoptotic signaling in neuroglia, macrophages, lymphocytes and endothelial cells. This platform aims to facilitate the development of predictive paradigms of nanoneurotoxicity based on mechanistic investigation of relevant in vivo bio-nanointerfaces.

From the Clinical Editor

This team of investigators report the development of a platform that enables screening of iron oxide nanoparticles from the standpoint of their potential neurotoxicity, utilizing rat sciatic nerves. Such screening tools are clearly needed with the potential advent of iron oxide nanoparticle-based diagnostic and therapeutic approaches.